ProPhase Labs, Inc. (PRPH) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Track ProPhase Labs, Inc. (PRPH) stock performance with short-term forecasts for 2025 and long-term PRPH price prediction till 2050. Review historical trends, get analyst Buy/Sell/Hold ratings, and stay updated with the latest ProPhase Labs, Inc. headlines.
1 Month Prediction
$7.47 [1298.97%]
3 Month Prediction
$5.53 [935.35%]
6 Month Prediction
$2.56 [379.73%]
1 Year Prediction
$1.00 [87.27%]
3 Year Prediction
$1.00 [87.27%]
5 Year Prediction
$1.00 [87.27%]
About ProPhase Labs, Inc.
ProPhase Labs, Inc. develops and sells diagnostic testing, genomic sequencing, and consumer health products.
The company owns Nebula Genomics, which provides whole genome sequencing services. ProPhase Diagnostics offers COVID-19 testing and respiratory pathogen screening. And, ProPhase Biopharma develops early detection tests for esophageal cancer and other diseases.
The company also sells dietary supplements through TK Supplements, including Legendz XL for male health and Triple Edge XL for energy and stamina.
ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.
ProPhase Labs, Inc. (PRPH) Historical Performance
IPO Date
ProPhase Labs, Inc. (NASDAQ:PRPH) went public on 16 January, 1984.
Change
Since inception, PRPH has increased by 972.17%. In the last 5 years, PRPH has fallen from $1.66 to $0.53, a massive -67.8% decrease since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $12.68 and a low of $0.26.
52 Week Range
$0.22
$7.48
The current price $0.53 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
PRPH Stock Price History
Based on PRPH stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the PRPH stock has fallen from $1.26 - $9.19 to $0.26 - $0.53, which is down -77.8%. Currently, the stock follows downward trend.
Here, we have calculated stock range of PRPH, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $1.26 - $9.19 | $3.31 | 83.7 | 1 Year Change |
| 2021 | $4.21 - $8.88 | $5.9 | 227.44 | 2 Year Change |
| 2022 | $5.82 - $12.68 | $9.47 | 425.57 | 3 Year Change |
| 2023 | $4.28 - $9.49 | $6.44 | 257.41 | 4 Year Change |
| 2024 | $0.76 - $6.47 | $3.48 | 93.13 | 5 Year Change |
| 2025 | $0.26 - $0.53 | $0.4 | -77.8 | 6 Year Change |
PRPH Price Performance
6-Month Performance
PRPH stock dropped by 77.93% in the last six months.
1-Year Performance
The stock has trended downwards by 91.75% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 92.09%.
5-Year Performance
In the last 5 years, the stock has gone down by 67.80%.
According to ProPhase Labs, Inc.'s historical data, below graph gives us the exact picture of how the PRPH stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 2 years and a decline in 3 years.
2020
425.73% ↑
2021
18.04% ↓
2022
45.87% ↑
2023
53.06% ↓
2024
83.19% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
ProPhase Labs, Inc. (PRPH) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $3.15 M (Q3)
Revenue for Q3 ending 30th September, 2024 increased 27.16% compared to Q2 ending 30th June, 2024.
Annual Revenue: $12.75 M (1Y)
Revenue for trailing 12 months decreased 71.27% year over year from 31st December, 2023.
If compared to the last 5 years, the revenue has gone down from $14.51 million to $12.75 million, a 12.13% change.
Market Capitalization
ProPhase Labs, Inc. has a market capitalization of $16.14M, which places PRPH in the nano-cap category.
Fundamental Analysis
EPS: $-0.35 (Q3), $-0.98 (1Y)
EPS increased 6.06% since last quarter, and decreased 183.76% since last year.
Net Income: $-6.59 M (Q3), $-16.78 M (1Y)
Net Income increased 7.05% since last quarter, and decreased 190.90% since last year.
Free Cash Flow: $-4.21 M (Q3), $-14.50 M (1Y)
Free Cash Flow decreased 13.17% since last quarter, and decreased 158.88% since last year.
Net Profit Margin: -209.38% (Q3), -131.59% (1Y)
Net Profit Margin decreased 15.81% since last quarter, and decreased 416.34% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for PRPH stock. These indicators help you understand ProPhase Labs, Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for PRPH stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $0.37 |
| SMA50 | $0.55 |
| SMA200 | $2.35 |
| RSI | 79.40 |
| Beta | -0.35 |
SMA20 < Current Price
This signals PRPH stock is in short-term bullish momentum.
SMA50 > Current Price
This signals PRPH stock is in mid-term bearish momentum.
SMA200 > Current Price
This signals PRPH stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for PRPH stock is Bearish. Out of all indicators, 1 indicates bullish signals, 5 signals bearish trends and 3 gives neutral trends. The PRPH stock forecast was last updated on 23 February, 2025.
ProPhase Labs, Inc. (PRPH) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $1.00 by the end of 2025, and can reach around $0.21 to $1.51 in 2026. And, the long-term forecast suggests that the stock may further jump to $1.45 - $1.34 in 2028, and $1.02 - $0.91 by 2031. So, the PRPH stock shows a strong upward trend in the next several years.
Short-term PRPH Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-03 | $7.47 | 1298.88% |
| 2025-04 | $5.24 | 881.27% |
| 2025-05 | $5.53 | 935.58% |
| 2025-06 | $4.38 | 720.22% |
| 2025-07 | $3.09 | 478.65% |
| 2025-08 | $2.56 | 379.4% |
| 2025-09 | $1.00 | 87.27% |
| 2025-10 | $1.00 | 87.27% |
| 2025-11 | $1.00 | 87.27% |
| 2025-12 | $1.00 | 87.27% |
In 2025, the PRPH stock price is expected to fluctuate between $1.0 and $7.47. According to the monthly forecast, the stock could rise to $1.00 by December 2024. If compared to the PRPH's current price, the stock could gain 87.27% by the end of this year.
Long-term PRPH Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $0.21 | $0.96 | $1.51 | 182.77% |
| 2027 | $1.10 | $1.03 | $0.55 | 3.0% |
| 2028 | $1.45 | $1.19 | $1.34 | 150.94% |
| 2029 | $1.29 | $0.95 | $1.27 | 137.83% |
| 2030 | $1.53 | $1.08 | $0.88 | 64.79% |
| 2031 | $1.02 | $0.86 | $0.91 | 70.41% |
| 2032 | $1.36 | $0.49 | $0.75 | 40.45% |
| 2033 | $1.41 | $1.31 | $0.97 | 81.65% |
| 2034 | $0.92 | $0.86 | $0.99 | 85.39% |
| 2035 | $0.90 | $1.20 | $0.64 | 19.85% |
| 2036 | $0.49 | $1.41 | $1.11 | 107.87% |
| 2037 | $0.81 | $0.66 | $0.44 | -17.6% |
| 2038 | $1.02 | $0.91 | $0.79 | 47.94% |
| 2039 | $1.58 | $1.03 | $1.05 | 96.63% |
| 2040 | $0.67 | $1.17 | $1.35 | 152.81% |
| 2041 | $0.85 | $1.62 | $1.34 | 150.94% |
| 2042 | $0.93 | $1.26 | $1.24 | 132.21% |
| 2043 | $0.73 | $1.42 | $0.98 | 83.52% |
| 2044 | $1.10 | $0.95 | $0.69 | 29.21% |
| 2045 | $0.41 | $0.43 | $1.24 | 132.21% |
| 2046 | $1.38 | $0.90 | $0.83 | 55.43% |
| 2047 | $1.77 | $0.31 | $1.10 | 105.99% |
| 2048 | $1.05 | $1.58 | $1.03 | 92.88% |
| 2049 | $1.24 | $1.30 | $0.92 | 72.28% |
| 2050 | $1.03 | $0.17 | $0.53 | -0.75% |
| 2051 | $1.09 | $1.28 | $0.61 | 14.23% |
ProPhase Labs, Inc. (PRPH) Stock Price Prediction & Forecast 2025
At the start of 2025, the PRPH stock was at $0.26. Today, it is trading at $0.53, which is 105.38% increase from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $1.00 by December 2025 with a 87.27% change.
ProPhase Labs, Inc. (PRPH) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant appreciation in the PRPH stock. During this period, the PRPH's price is forecasted to shift from $0.21 to $0.88, which is 319.05% gain.
In 2026, the stock would possibly open at $0.21, escalates to $0.96 by mid-year, and wraps up at $1.51, reflecting a 181.88% increase from today's price. Further moving to 2030, the stock can kick off the year at $1.53, soar to $1.08 by mid-year, and finish at $0.88, which is 64.94% change from current price.
ProPhase Labs, Inc. (PRPH) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $1.02 to $1.35, which is up 69.92%
In 2031, we can expect PRPH to fluctuate between $0.91 and $1.02, a shift indicating a 69.92% gain by year-end compared to current price. And Until 2040, PRPH can likely vary from $0.67 to $1.35. By the end of 2040, the stock could record a 151.93% rise from today's stock price.
ProPhase Labs, Inc. (PRPH) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the PRPH stock can see an a downturn from $0.85 to $0.53 in this period. In 2041, the stock can experience a high of $1.62 by mid-year, closing the year at $1.34. This results in a 204.31% increase from today.
Moving towards the end of 2050, PRPH is projected to open the year at $1.03. The stock may dip to $0.17 during mid-year and finish the year at $0.53. Compared to the stock's current price, this translates to an overall loss of -1.07% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
PRPH : Buy, Sell Or Hold?
Analyst Ratings
Sorry, No analyst ratings available for this stock.
Expert Analysis
According to PRPH short-term and long-term forecast, ProPhase Labs, Inc. shares are projected to go down by 0.75%, and reach a value of $0.53 per share by 2050.
As per technical analysis, indicators show a Bearish sentiment, while Fear & Greed Index stands at 42.857142857142854, which signals Fear. Also, PRPH has recorded 7/30 green days, which reflects a 31.818181818181817% positivity rate with a price volatility of 0.14%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that PRPH stock is undervalued. So, Based on PRPH prediction and analysis, it may be the best time to sell PRPH stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "PRPH” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.